Christopher Kent

Christopher Kent

Chief Executive Officer, PhD, ODS Medical

Technology / Oncology

Revolutionary brain laser that zooms in on cancer cells. Christopher Kent it also the one of the finalist for the MEDTECH Innovator Showcase in the USA. He’s a very good speaker.

Biographie
Chris has expertise in cancer cell biology, and the management of early-stage start-ups. Prior to ODS, he worked with Dr. Kevin Petrecca to build a translational research program at the Montreal Neurological Institute focused on working with industry partners to accelerate development of treatments for brain cancers. In parallel, Chris spearheaded efforts in commercialization of in-house discoveries related to brain cancers. He has also published numerous peer-reviewed journal articles. Prior to his work at the MNI, Chris was Director of Business Development and IP strategy at Bioastra Technologies, a start-up that specialized in the application of stimuli-responsive polymer materials to a wide range of industries. In this role, he developed the company’s business model, leveraging strategic industry collaborations in sectors such as packaging, textiles, energy and life sciences, into a growing patent portfolio which through subsequent development and out-licensing deals grew the company’s revenue ten-fold.